Filing Flows › Sotera Health (SHC) › Sterigenics revenue
Sotera Health (SHC) Sterigenics revenue by quarter
Sotera Health's Sterigenics revenue was $209M in Q3 2026 (third quarter 2026), -1% from Q2 2026. Over the last 7 quarters it ranged from $170M (Q1 2025) to $212M (Q2 2026).
| Quarter | Sterigenics revenue | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $209M | -1% | +9% |
| Q2 2026 | $212M | +14% | +9% |
| Q1 2026 | $186M | -6% | +10% |
| Q4 2025 | $198M | +3% | — |
| Q3 2025 | $193M | -1% | — |
| Q2 2025 | $195M | +15% | — |
| Q1 2025 | $170M | — | — |
Q3 2026 at a glance
Sotera Health, Q3 2026: revenue $325M (+4% year over year), operating margin 25.8%, net earnings $58.4M, operating cash flow $111M. The chart follows the revenue to costs, profit and cash.
Questions
What is Sotera Health's Sterigenics revenue?
Sotera Health's Sterigenics revenue was $209M in Q3 2026 (third quarter 2026), -1% from Q2 2026.
How has Sotera Health's Sterigenics revenue changed?
Over the last 7 quarters it ranged from $170M (Q1 2025) to $212M (Q2 2026).